Medicare Enrolled
Dr. Vivek Rudrapatna, M.D.
Internal Medicine · Salinas, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rudrapatna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rudrapatna?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rudrapatna
Dr. Vivek Rudrapatna is an internal medicine specialist in Salinas, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Rudrapatna performed 10,565 Medicare services across 3,412 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rudrapatna received a total of $14,612 from 50 pharmaceutical and/or device companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rudrapatna is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 2% volume in CA
$14,612 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,565
Medicare services
Top 2% in CA for internal medicine
3,412
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~587 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 6,480 | $18 | $38 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
887 | $47 | $167 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
505 | $52 | $250 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
394 | $8 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
203 | $26 | $233 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
186 | $10 | $55 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
177 | $8 | $37 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
163 | $37 | $213 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
161 | $33 | $52 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
150 | $30 | $103 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
146 | $10 | $67 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
141 | $72 | $89 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
126 | $13 | $88 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
101 | $52 | $158 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
84 | $10 | $55 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
73 | $52 | $167 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
60 | $44 | $347 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
54 | $0 | $12 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
53 | $44 | $100 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
53 | $128 | $328 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
40 | $282 | $709 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
34 | $16 | $97 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
34 | $33 | $35 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
33 | $59 | $247 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
28 | $16 | $34 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
27 | $2 | $22 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
27 | $10 | $51 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $42 | $99 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
21 | $41 | $166 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
20 | $22 | $58 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $98 | $382 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
17 | $121 | $382 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
15 | $19 | $99 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
14 | $100 | $427 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
12 | $8 | $48 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,612
Total received (2018-2024)
Avg $2,087/year across 7 years
Top 7% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
470
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,112 (55.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,500 (44.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,945
2023
$2,277
2022
$1,307
2021
$556
2020
$159
2019
$927
2018
$1,442
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
IRONWOOD PHARMACEUTICALS, INC
$6,500
ABBVIE INC.
$369
PFIZER INC.
$200
Amgen Inc.
$168
Lilly USA, LLC
$157
Novo Nordisk Inc
$146
Bayer Healthcare Pharmaceuticals Inc.
$142
E.R. Squibb & Sons, L.L.C.
$74
AstraZeneca Pharmaceuticals LP
$53
GlaxoSmithKline, LLC.
$53
Mylan Specialty L.P.
$49
Kyowa Kirin, Inc.
$19
ViiV Healthcare Company
$15
Top 3 companies account for 89.0% of 2024 payments
All-time payments by company (2018-2024) ›
IRONWOOD PHARMACEUTICALS, INC
$6,500
Amgen Inc.
$851
GlaxoSmithKline, LLC.
$788
AbbVie Inc.
$606
ABBVIE INC.
$604
Novo Nordisk Inc
$586
Lilly USA, LLC
$493
PFIZER INC.
$433
AstraZeneca Pharmaceuticals LP
$416
Abbott Laboratories
$391
Janssen Pharmaceuticals, Inc
$342
Bayer Healthcare Pharmaceuticals Inc.
$272
Boehringer Ingelheim Pharmaceuticals, Inc.
$212
SANOFI-AVENTIS U.S. LLC
$210
E.R. Squibb & Sons, L.L.C.
$192
IDORSIA PHARMACEUTICALS US INC
$191
Allergan Inc.
$166
Mylan Specialty L.P.
$157
Merck Sharp & Dohme Corporation
$101
Radius Health, Inc.
$100
Bayer HealthCare Pharmaceuticals Inc.
$95
Biohaven Pharmaceutical Holding Company Ltd.
$92
Merck Sharp & Dohme LLC
$62
AbbVie, Inc.
$61
Shire North American Group Inc
$49
Takeda Pharmaceuticals U.S.A., Inc.
$46
Novartis Pharmaceuticals Corporation
$46
SANOFI PASTEUR INC.
$45
Dexcom, Inc.
$43
Horizon Therapeutics plc
$38
ViiV Healthcare Company
$35
Kowa Pharmaceuticals America, Inc.
$34
Bioventus LLC
$32
Myriad Women's Health, Inc.
$26
Regeneron Healthcare Solutions, Inc.
$24
Sunovion Pharmaceuticals Inc.
$24
Sanofi Pasteur Inc.
$23
Amarin Pharma Inc.
$22
Gilead Sciences, Inc.
$21
Biohaven Pharmaceuticals, Inc.
$20
Daiichi Sankyo Inc.
$20
DEXCOM, INC.
$20
Kyowa Kirin, Inc.
$19
Phadia US Inc.
$19
Medtronic, Inc.
$18
Xeris Pharmaceuticals, Inc.
$15
Teva Pharmaceuticals USA, Inc.
$13
TherapeuticsMD, Inc.
$13
Hologic, LLC
$13
Allergan, Inc.
$12
Top 3 companies account for 55.7% of all-time payments
Associated products mentioned in payments ›
ADACEL · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APRETUDE · AREXVY · Aimovig · BEVESPI AEROSPHERE · BREO · BYSTOLIC · CAMZYOS · CHANTIX · COMIRNATY · CREON · Creon · DEXCOM G6 TRANSMITTER · DIFICID · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL 9 · GELSYN 3 · GEMTESA · GLYXAMBI · GVOKE PFS · HUMIRA · IMVEXXY · INJECTAFER · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LINZESS · LO LOESTRIN FE · LYRICA · Livalo · MOUNJARO · MYRISK · NAMZARIC · NATPARA (PARATHYROID HORMONE) · NEXPLANON · NUCALA · NURTEC ODT · Nourianz · NovoLog · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PRALUENT · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RINVOQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · ThinPrep · Tresiba · Trintellix · Tymlos · UBRELVY · VAXELIS · VENASEAL · VIBERZI · VIIBRYD · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (56%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
162
Per 100K population
37.2
County median income
$94,486
Nearest hospital
SALINAS VALLEY MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rudrapatna is a clinical cardiology specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 7% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rudrapatna experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Rudrapatna performed 6,480 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rudrapatna receive payments from pharmaceutical companies?
Yes. Dr. Rudrapatna received a total of $14,612 from 50 companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rudrapatna's costs compare to other internal medicine physicians in Salinas?
Dr. Rudrapatna's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rudrapatna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Salinas
Browse internal medicine physicians in Salinas ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
IRONWOOD PHARMACEUTICALS, INC Payments to Doctors
See all physicians who received payments from IRONWOOD PHARMACEUTICALS, INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology